Gross-tumor-volume segment-anything model for medical 2D images integrating gross tumor volume-minimal feature integration technology for lung cancer segmentation

用于肺癌分割的基于肿瘤体积的二维医学图像分割模型,该模型融合了肿瘤体积最小特征集成技术。

阅读:1

Abstract

BACKGROUND: Accurate segmentation of lung cancer gross tumor volume (GTV) on computed tomography (CT) is critical for radiotherapy planning yet remains difficult due to low tumor-tissue contrast, small target size, and high intratumoral heterogeneity. This study aimed to develop and validate an automatic method-a GTV segment-anything model generative adversarial network (GTV-SAMGAN)-for accurate, robust, and clinically efficient GTV segmentation on CT, with particular emphasis on small, low-contrast, and heterogeneous lesions. METHODS: We propose GTV-SAMGAN, built upon SAM medical 2D image (SAM-Med2D), integrating a newly developed GTV-minimal feature integration technology MFIT (GTV-MFIT) module with a GAN-based training scheme. The performance of GTV-SAMGAN was evaluated on a local clinical dataset and a public non-small cell lung cancer-radiomics (NSCLC-Radiomics) dataset (https://wiki.cancerimagingarchive.net/display/Public/NSCLC-Radiomics). We compared the proposed model against representative baselines (including SAM-Med2D and SwinU-Net) using the Dice coefficient, sensitivity, and specificity. RESULTS: On the local dataset, GTV-SAMGAN achieved a Dice coefficient of 83.74%, a sensitivity of 84.28%, and a specificity 99.98%, outperforming the other models. Compared to SwinU-Net, GTV-SAMGAN increased the Dice coefficient and sensitivity by 10.71% and 10.15%, respectively; compared to SAM-Med2D, it increased the Dice coefficient and sensitivity by 7.69% and 7.75%, respectively. On the NSCLC-Radiomics dataset, GTV-SAMGAN achieved a Dice coefficient of 82.92% and a sensitivity of 82.25%, representing an improvement over SAM-Med2D of 6.68% and 9.61%, respectively. CONCLUSIONS: By coupling SAM-Med2D with GTV-MFIT and GAN training, GTV-SAMGAN substantially improves lung cancer GTV segmentation, particularly for small and heterogeneous tumors, thereby enhancing the precision and efficiency of radiotherapy planning.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。